Physiologically-based pharmacokinetic modeling for primary metabolites of CYP3A and P-glycoprotein inhibitors in drug-drug interactions: Should we assume the free drug hypothesis?

ABSTRACT:

SUBMITTER: Yamazaki S 

PROVIDER: S-EPMC9835114 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature